From Euroz Nov report on BOT..which is on BOT site..
Euroz analyst talk of Net sales , meaning Gross profit based on 287 000 prescriptions ...meaning for every usd 700 Gross sales we get usd 540 net ( paying approx 22% for cost of production and distribution, sharing with derma clinics)..
! Important ! This does not account for 3x US population...we can have a nice UPSIDE!
"United States, underscoring the considerable market opportunity at hand.Based on our analysis, we estimate Kaken sold ~72,000 prescriptions in 2Q, or +287,000prescriptions on an annualised basis (Figure 4).More so, when applied to our estimate of US pricing (US$540/month; net), thisannualised 2Q prescription figure implies ~A$239 million of annual revenues in theUnited States (Figure 5).Additionally, this is based on Japanese prescription volumes, the United States has apopulation nearly 3x larger than Japan – which would suggest even larger potentialprescription volumes and sales are possible. We provide the full analysis below."
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-6990
-
- There are more pages in this discussion • 2,283 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
37.5¢ | 38.0¢ | 35.0¢ | $4.519M | 12.27M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 75362 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 326113 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 75362 | 0.370 |
6 | 558703 | 0.365 |
9 | 743928 | 0.360 |
9 | 906267 | 0.355 |
8 | 646888 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 326113 | 17 |
0.385 | 207424 | 8 |
0.390 | 723886 | 12 |
0.395 | 338769 | 11 |
0.400 | 1147131 | 24 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online